EP Patent

EP0360562B1 — Directly compressible sustained release excipient

Assigned to Penwest Pharmaceuticals Co · Expires 1993-07-28 · 33y expired

What this patent protects

A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes a heteropolysaccharide and a polysaccharide material capable of cross-linking the heteropolysaccharide, a…

USPTO Abstract

A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes a heteropolysaccharide and a polysaccharide material capable of cross-linking the heteropolysaccharide, and an inert diluent.

Drugs covered by this patent

Patent Metadata

Patent number
EP0360562B1
Jurisdiction
EP
Classification
—
Expires
1993-07-28
Drug substance claim
No
Drug product claim
No
Assignee
Penwest Pharmaceuticals Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.